Chronic Obstructive Pulmonary Disease (COPD)

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home – a Multi-center Randomized Controlled Trial

NCT05204888

Sponsors: Temple University

The purpose of this trial is to evaluate whether home use of the myAirvo 3 device (High Flow Nasal Therapy, HFNT) improves outcomes for patients with moderate to very severe COPD compared to usual medical care. Specifically, it aims to determine if HFNT can delay or reduce exacerbations, hospitalizations, and mortality, while also improving quality of life.